The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: A qualitative study

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Berry, Scott R ^a,b   Hubay, Stacey ^c   Soibelman, Hagit ^b   Martin, Douglas K ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Grand River Regional Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CENTER; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; FUNDING; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL PRACTICE; ONCOLOGY; ONCOLOGY WARD; PERCEPTION; PHYSICIAN; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; CANADA; DOCTOR PATIENT RELATION; DRUG APPROVAL; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH PERSONNEL ATTITUDE; INTERVIEW; LEGAL ASPECT; MANAGEMENT; NEOPLASM; PATIENT ADVOCACY; PROFESSIONAL PRACTICE;

ANTINEOPLASTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; DRUG APPROVAL; FEMALE; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICAL ONCOLOGY; NEOPLASMS; ONTARIO; PATIENT ADVOCACY; PHYSICIAN-PATIENT RELATIONS; PRACTICE MANAGEMENT, MEDICAL; PROFESSIONAL AUTONOMY; QUALITATIVE RESEARCH;

EID: 37349020637     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-193     Document Type: Article

References (15)

1. Changing Physicians' Practices. PJ Greco JM Eisenberg, N Engl J Med 1993 329 17 1271 4 10.1056/NEJM199310213291714 8413397
2. Clinical policies and the quality of clinical practice. DM Eddy, N Engl J Med 1982 307 6 343 7 7088099
3. Canadian Cancer Society/National Cancer Institute of Canada, Canadian Cancer Statistics 2006. Toronto, Canada 2006
4. R Moore Y Mao J Zhang K Clarke, Economic Burden of Illness in Canada Ottawa: Health Canada 1997
5. Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle. JL Pater GP Browman MC Brouwers MF Nefsky WK Evans DH Cowan, J Clin Oncol 2001 19 14 3392 6 11454887
6. Priority-setting decisions for new cancer drugs: a qualitative case study. DK Martin JL Pater PA Singer, Lancet 2001 358 1676 1681 10.1016/S0140-6736(01)06714-9 11728542
7. Priority setting for new technologies in medicine: qualitative case study. PA Singer DK Martin M Giacomini L Purdy, BMJ 2000 321 7272 1316 18 11090513 10.1136/bmj.321.7272.1316
8. Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold. R Foy J So E Rous JH Scarffe, BMJ 1999 318 7181 456 59 9974468
9. Accountability for reasonableness. N Daniels, BMJ 2000 321 7272 1300 01 11090498 10.1136/bmj.321.7272.1300
10. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Provincial Lung Disease Site Group of Cancer Care Ontario. ID Graham WK Evans D Logan A O'Connor V Palda L McAuley M Brouwers MB Harrison, Oncology 2000 59 4 283 90 10.1159/000012184 11096339
11. The doctor's master. NG Levinsky, N Engl J Med 1984 311 24 1573 5 6438510
12. Communication skills in palliative care: a practical guide. R Buckman, Neurol Clin 2001 19 4 989 1004 10.1016/S0733-8619(05)70057-8 11854110
13. SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. WF Baile R Buckman R Lenzi G Glober EA Beale AP Kudelka, Oncologist 2000 5 4 302 11 10.1634/theoncologist.5-4-302 10964998
14. Breaking bad news: impact of a continuing medical education workshop. R Ladouceur F Goulet R Gagnon R Boule G Girard A Jacques J Frenette R Carrier, J Palliat Care 2003 19 4 238 45 14959593
15. Caring and cost: the challenge for physician advocacy. SD Pearson, Ann Intern Med 2000 133 2 148 53 10896641